Post written by Iris J.M. Levink, MD, from the Department of Gastroenterology & Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands. We aimed to develop a panel of biomarkers from serum and pancreatic juice (PJ) to detect pancreatic ductal adenocarcinoma for future surveillance purposes. This study focused on the performance of proteins (interleukin-8 [IL-8]; interferon-γ [IFN-γ]; …
Tag: biomarker
HMGA2 protein as a biomarker of dysplasia in IPMN
Christopher J. DiMaio, MD, FASGE, from the Icahn School of Medicine at Mount Sinai, Mount Sinai Medical Center, in New York, New York, USA discusses his article "Pancreatic cyst fluid concentration of high-mobility group A2 protein acts as a differential biomarker of dysplasia in intraductal papillary mucinous neoplasm." No reliable cyst fluid biomarkers exist that …
Continue reading HMGA2 protein as a biomarker of dysplasia in IPMN
endoscopedia.com 